Valproate plasma protein binding in the uremic condition
- PMID: 6985855
- DOI: 10.1038/clpt.1980.12
Valproate plasma protein binding in the uremic condition
Abstract
The protein binding of sodium [carboxy-14C] valproate has been studied in normal and uremic plasma using the method of equilibrium dialysis. Protein binding was dependent on concentration in both cases but there was a marked reduction in binding capacity in patients with renal dysfunction. Treatment of normal plasma with urea or creatinine to reproduce concentrations observed in uremia induced small decreases in binding. Diffusion dialysis of uremic plasma partially restored the degree of binding. Pretreatment of uremic plasma with activated charcoal at pH 3 raised binding capacity to that of normal plasma.
Similar articles
-
Diminished protein binding capacity of uremic sera for valproate following hemodialysis: role of free fatty acids and uremic compounds.Am J Nephrol. 1996;16(4):327-33. doi: 10.1159/000169018. Am J Nephrol. 1996. PMID: 8739287
-
Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.Am J Clin Pathol. 1994 Mar;101(3):349-53. Am J Clin Pathol. 1994. PMID: 8135194
-
Correction of protein binding defect in uremic sera by charcoal treatment.J Lab Clin Med. 1976 Apr;87(4):637-47. J Lab Clin Med. 1976. PMID: 1270877
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Effect of disease states on plasma protein binding of drugs.Med Clin North Am. 1974 Sep;58(5):1103-9. doi: 10.1016/s0025-7125(16)32106-x. Med Clin North Am. 1974. PMID: 4607741 Review. No abstract available.
Cited by
-
The effects of peritoneal dialysis on the single dose and steady state pharmacokinetics of valproic acid in a uremic epileptic child.Eur J Clin Pharmacol. 1983;24(3):387-90. doi: 10.1007/BF00610060. Eur J Clin Pharmacol. 1983. PMID: 6407847
-
Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.J Med Toxicol. 2007 Sep;3(3):129-38. doi: 10.1007/BF03160923. J Med Toxicol. 2007. PMID: 18072149 Free PMC article. No abstract available.
-
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).Clin Pharmacokinet. 1990 Sep;19(3):218-29. doi: 10.2165/00003088-199019030-00005. Clin Pharmacokinet. 1990. PMID: 2203581 Review.
-
Alteration of drug-protein binding in renal disease.Clin Pharmacokinet. 1984 Jan;9 Suppl 1:18-26. doi: 10.2165/00003088-198400091-00003. Clin Pharmacokinet. 1984. PMID: 6705423
-
Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease.Eur J Clin Pharmacol. 1985;28(4):447-52. doi: 10.1007/BF00544365. Eur J Clin Pharmacol. 1985. PMID: 3928388
MeSH terms
Substances
LinkOut - more resources
Full Text Sources